Navigation Links
Saladax Biomedical, Inc. Names Edward Chu, M.D., Chair of the Company's Scientific Advisory Board
Date:11/1/2011

ack record, we are confident his expertise will help our company's unique diagnostic products expand globally."

"Given my background, I'm eager to contribute to Saladax's goal of personalizing patient care through the company's MyCare™ platform and companion diagnostic products," said Dr. Chu.  "Saladax's technology has the potential to revolutionize the way physicians manage and administer cancer treatment for their patients who are in great need of personalized and targeted care."

Dr. Chu is a graduate of Brown University with B.S., M.M.S., and M.D. degrees and also completed his residency training in internal medicine at Brown before moving to the NCI where he completed a fellowship in medical oncology.  Dr. Chu is also the editor-in-chief for "Clinical Colorectal Cancer," a member of the scientific advisory boards of the Taiwan National Institute of Cancer Research, Albert Einstein Cancer Center and the Dartmouth Norris Cancer Center.  Dr. Chu is also serving as a full member for the NIH/NCI IRG Subcommittee A Study Section until 2012.  He is also the author of the "Physicians' Cancer Chemotherapy Drug Manual," which provides a comprehensive review of all major cancer drugs and drug treatment regimens currently used in daily clinical practice by medical oncologists and health care professionals.  The manual is recognized as a leading publication in the cancer field.  

Because of his extensive experience, Dr. Chu has received the "New York Magazine Top Doctor for Cancer (Medical Oncology)" and the "Castle Connolly American's Top Doctor for Cancer" every year since 2005.  In 2005, he was also elected as a fellow for the American Association for the Advancement of Science (AAAS).

About Saladax Biomedical, Inc.

Saladax Biomedical develops and commercializes novel diagnostic assays to achieve the promise of personalized medicine through dose management and companion diagnostic product
'/>"/>

SOURCE Saladax Biomedical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Saladax Biomedical, Inc. Enters Agreement with Kaan Medikal for Distribution of My5-FU in Turkey
2. Saladax Biomedical, Inc. Completes $9 Million Debt Financing With GE Capital
3. Saladax Biomedical, Inc. Announces Pacific Rim Commercialization Team in Australia and China
4. Saladax Biomedicals 5-FU Personalized Chemotherapy Management (PCM(R)) Assay CE Marked for Distribution in the EU
5. Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc. Enter Strategic Partnership on Anti-Cancer Drugs Targeting Cancer Stem Cells
6. BINDER BIOMEDICAL, INC. Announces Official Launch of the NEWTON™ Intervertebral Body Fusion Spinal Spacer System
7. Binder Biomedical, Inc. Announces the Release of the X-GRAFT(TM) Interspinous Device, as Part of Their QUANTUM(TM) Line of Spinal Allograft Devices, Manufactured at the University of Miami Tissue Bank
8. Digital Assent Names Frank Garland Vice President of Advertising Sales
9. White Smile Global Inc. (WSML) Names Dr. Martin S. Giniger, D.M.D., Ph.D., MsD, FICD New Scientific Director Bringing Decades of Proven Scientific Advancements to Create the All New White Smile™ Organic Product Line
10. vRad Names Radiology Industry Leader Jim Tierney to Head Expanding vRad Radiology Alliance
11. Codexis Names Veteran Chemical Executive to Lead Codexis do Brasil
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment ... Chief Executive Officer.  Mark was promoted from his current role ... company,s four facilities in Massachusetts , ... Tegra Medical in 2012 with 20+ years of broad-based operations, ...
(Date:1/15/2014)... Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), a ... a non-invasive, wireless continuous glucose monitoring system, today announced ... Interim CEO of Echo Therapeutics, will present at "TEN", ... Mr. Doman will make a corporate presentation ...
(Date:1/15/2014)... TORONTO , Jan. 15, 2014  According to ... medical technology market intelligence, the United ... occlusion (TEO) device markets will expand moderately through ... fastest-growing segments. In particular, increasing interest in drug-eluting ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... to anti-clotting drug, CHICAGO, March 29 ... dose of a medication that prevents blood clotting,significantly ... coronary interventions (PCI), according to a multicenter study,reported ... the SCAI,Annual Scientific Sessions in Partnership with ACC ...
... ,culotte, technique better?, CHICAGO, March 29 When ... of two coronary arteries -- or a,bifurcation lesion -- ... vessels without blocking the opening to the side branch. ... on which of,two techniques produces the best long-term results ...
Cached Medicine Technology:Tailored Clopidogrel Dosing Improves PCI Outcomes 2Tailored Clopidogrel Dosing Improves PCI Outcomes 3Stenting Techniques Vie in Branchpoint Lesions 2
(Date:4/14/2014)... Doctors at Henry Ford Hospital reached a medical ... replacement using a novel way to access the heart. ... United States performing the unique procedure called transcaval valve ... blood vessels. , Northern Michigan resident Viola Waller, 80, ...
(Date:4/14/2014)... , , Penicillin, one of the scientific marvels of the ... it once won against bacterial infections. But scientists at ... new approach to restoring its combat effectiveness, even against ... the power of the penicillin family of drugs since ...
(Date:4/14/2014)... their radiation treatment decisions leaves cancer patients feeling more ... distress around the experience, researchers from the Perelman ... report in the journal Cancer . , In ... Neha Vapiwala, MD , an associate professor in the ...
(Date:4/14/2014)... Popular web information on colorectal cancer is too ... address the appropriate risks to and concerns of patients, ... , In a review of a dozen popular websites, ... cancer screening were written beyond the recommended sixth-grade reading ...
(Date:4/14/2014)... the molecule, called microRNA 135b, is a vital ,worker, ... growth of bowel cancers. , Drugs targeted at the ... mutations at once, while tests for it could identify ... , The research was carried out by an international ...
Breaking Medicine News(10 mins):Health News:Henry Ford Hospital hits new heart valve surgery milestone 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 3Health News:Shared decision making during radiation therapy improves patient satisfaction 2Health News:Shared decision making during radiation therapy improves patient satisfaction 3Health News:Website information on colon cancer too complex, fails to address key concerns 2Health News:Website information on colon cancer too complex, fails to address key concerns 3Health News:'MicroRNA' could be key target for bowel cancer treatment 2
... French . , Montreal, February 22, 2010 ... young immigrants. A new study published in the Journal ... children from multiethnic, disadvantaged, inner-city neighbourhoods are up to 3.5 ... an estimated 45,000 school-aged children immigrate to Canada with their ...
... URBANA - A University of Illinois researcher advises caution ... this country,s Latino adolescents and young adults. "When ... in a 90-minute program, the Latino students in my classes ... were right!" said Marcela Raffaelli, a U of I professor ...
... ... Boehringer Ingelheim (Canada) Ltd. , ... Toronto, Ontario, Canada (PRWEB) February 22, 2010 -- Dalton Pharma Services announces ... the agreement Dalton will continue to provide chemistry services in support of Boehringer,s pharmaceutical ...
... life, researchers say , MONDAY, Feb. 22 (HealthDay News) ... causes low energy levels and reduced quality of life, ... a new study suggests. , About 15 percent of ... late side effect of chemotherapy or radiation therapy. , ...
... ... ... ... ...
... , ... ... ... ...
Cached Medicine News:Health News:Are Latino teens sexual risk takers? It's complicated, researcher says 2Health News:Are Latino teens sexual risk takers? It's complicated, researcher says 3Health News:Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement 2Health News:Testicular Cancer Survivors May Have Hormone Deficiency 2Health News:Anshen + Allen Uses ArchiCAD to Transform Shipping Containers Into Clinics for the Developing World 2Health News:Anshen + Allen Uses ArchiCAD to Transform Shipping Containers Into Clinics for the Developing World 3Health News:Anshen + Allen Uses ArchiCAD to Transform Shipping Containers Into Clinics for the Developing World 4Health News:Anshen + Allen Uses ArchiCAD to Transform Shipping Containers Into Clinics for the Developing World 5Health News:Anshen + Allen Uses ArchiCAD to Transform Shipping Containers Into Clinics for the Developing World 6Health News:57 Year-Old Grandmother Travels to Atacama Desert to Run First of Four Ultramarathons for Charity 2Health News:57 Year-Old Grandmother Travels to Atacama Desert to Run First of Four Ultramarathons for Charity 3Health News:57 Year-Old Grandmother Travels to Atacama Desert to Run First of Four Ultramarathons for Charity 4Health News:57 Year-Old Grandmother Travels to Atacama Desert to Run First of Four Ultramarathons for Charity 5Health News:57 Year-Old Grandmother Travels to Atacama Desert to Run First of Four Ultramarathons for Charity 6
... , , The Shortyavailable with both Impact ... our face-to-face relationship with the scientific community generates ... pipetting easier and more effective., Shorter and ... Gets you closer to the working area ...
... Powerful and Flexible Impact And Impact2 Pipettors ... volume ranges, our single channel Impact and ... of any application. Engineered with the same ... multichannel line, these pipettors are equally easy ...
... And Impact2 Pipettors , , Available ... channel Impact and Impact2 pipettors can effectively ... with the same ergonomic design and superior ... are equally easy to program for a ...
... The Finnpipette BioControl is a ... technology. A complete liquid handling system ... twelve interchangeable tip cone modules. All ... tip cone modules fit one handle. ...
Medicine Products: